HomeInvestors

Investors

The leading global supplier
of Tongkat Ali extract

Growing on three fronts: ingredients for brands worldwide, contract manufacturing and health products in Malaysia.

The extraction hall at the Phytes Biotek plant
RM26.7mGroup revenue in 2025, up 13%
36Countries
400+Products made with Physta
28Human studies on Physta

Built on evidence and patents

Its flagship ingredient, Physta®, is backed by 28 human studies and patents in the United States, Europe and Malaysia.

See the research at tongkatali.com

Company
Biotropics Malaysia Berhad, 200701004244 (762243-P)
Founded
2007
Owner
TAB Capital
Employees
62
Revenue
RM26.7 million in 2025, up 13% (group, audited)

Protected by patents

42 active patents in the United States, Malaysia and other countries, from 16 patent families across Biotropics’ ingredients. They include:

  • 2021 · US 11,058,737 B2Women’s health: hormonal imbalance and menopause
  • 2021 · US 11,166,998 B2Immune health
  • 2021 · MY 183659 AKidney protection
  • 2022 · MY 189837 AAntiviral use
Investor relations

Talk to us

For introductions, company information and meetings.

Leadership

Media kit

Investor enquiry